PD-L1 Immunohistochemistry Comparability and Their Correlation with Clinical Characteristics in NSCLC

Figure 2

Overall agreement in 106 patients with PD-L1 using all three assays at a cut-off of 1% (a–c) and at a cut-off of 50% (d–f). Venn diagrams showing the positive (b, e) and negative agreement (c, f) at cut-offs of 1% (b, c) and 50% (e, f).

(a)

(b)

(c)

(d)

(e)

(f)